Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 51

Sort by

Sort Order Select

Journal Articles

Spotlight on eltrombopag in pediatric ITP in China: a long-term observational study in real-world practice

Xiaoling Cheng, LingLing Fu, Jingyao Ma, Hao Gu, Zhenping Chen, Libo Zhao, Xiaoling Wang, Runhui Wu

Blood Adv (2021) 5 (19): 3799–3806.

https://doi.org/10.1182/bloodadvances.2020004110

Published: 2021

Journal Articles

Targeting pediatric leukemia-propagating cells with anti-CD200 antibody therapy

Paraskevi Diamanti, Charlotte V. Cox, Benjamin C. Ede, Robert A. Uger, John P. Moppett, Allison Blair

Blood Adv (2021) 5 (18): 3694–3708.

https://doi.org/10.1182/bloodadvances.2020003534

Published: 2021

Includes: Supplemental data

Journal Articles

IFN-γ signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRS

Blood Adv (2021) 5 (17): 3457–3467.

https://doi.org/10.1182/bloodadvances.2021004287

Published: 2021

Includes: Supplemental data

Journal Articles

The predictive value of PNH clones, 6p CN-LOH, and clonal TCR gene rearrangement for aplastic anemia diagnosis

Yash B. Shah, Salvatore F. Priore, Yimei Li, Chi N. Tang, Peter Nicholas, Peter Kurre, Timothy S. Olson, Daria V. Babushok

Blood Adv (2021) 5 (16): 3216–3226.

https://doi.org/10.1182/bloodadvances.2021004201

Published: 2021

Includes: Supplemental data

Journal Articles

A phase 2 study of nilotinib in pediatric patients with CML: long-term update on growth retardation and safety

Blood Adv (2021) 5 (14): 2925–2934.

https://doi.org/10.1182/bloodadvances.2020003759

Published: 2021

Includes: Supplemental data

Journal Articles

Transplant-associated thrombotic microangiopathy in pediatric patients: pre-HSCT risk stratification and prophylaxis

Christine S. Higham, Griffin Collins, Kristin A. Shimano, Alexis Melton, Sandhya Kharbanda, Lena E. Winestone, James N. Huang, Jasmeen Dara, Janel R. Long-Boyle, Christopher C. Dvorak

Blood Adv (2021) 5 (8): 2106–2114.

https://doi.org/10.1182/bloodadvances.2020003988

Published: 2021

Includes: Supplemental data

Journal Articles

Misdiagnosed thrombocytopenia in children and adolescents: analysis of the Pediatric and Adult Registry on Chronic ITP

Alexandra Schifferli, Andrea Heiri, Paul Imbach, Susanne Holzhauer, Markus G. Seidel, Diane Nugent, Marc Michel, Thomas Kühne

Blood Adv (2021) 5 (6): 1617–1626.

https://doi.org/10.1182/bloodadvances.2020003004

Published: 2021

Journal Articles

Evolutionary insights into coagulation factor IX Padua and other high-specific-activity variants

Benjamin J. Samelson-Jones, Jonathan D. Finn, Leslie J. Raffini, Elizabeth P. Merricks, Rodney M. Camire, Timothy C. Nichols, Valder R. Arruda

Blood Adv (2021) 5 (5): 1324–1332.

https://doi.org/10.1182/bloodadvances.2019000405

Published: 2021

Includes: Supplemental data

Journal Articles

Outcomes and prognostic factors in adolescents and young adults with ALL treated with a modified BFM-90 protocol

Akhil Rajendra, Hasmukh Jain, V. N. Avinash Bonda, Lingaraj Nayak, Prashant Tembhare, Dhanlaxmi Shetty, Jayashree Thorat, Hemani Jain, Papagudi Ganesan Subramanian, Nikhil Patkar, Gaurav Chatterjee, Navin Khattry, Anant Gokarn, Sachin Punatar, Smruti Mokal, Bhausaheb Bagal, Manju Sengar

Blood Adv (2021) 5 (5): 1178–1193.

https://doi.org/10.1182/bloodadvances.2020003526

Published: 2021

Includes: Supplemental data

Journal Articles

Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets

Blood Adv (2021) 5 (3): 900–912.

https://doi.org/10.1182/bloodadvances.2020003709

Published: 2021

Includes: Supplemental data

Journal Articles

Thioridazine requires calcium influx to induce MLL-AF6 –rearranged AML cell death

Claudia Tregnago, Ambra Da Ros, Elena Porcù, Maddalena Benetton, Manuela Simonato, Luca Simula, Giulia Borella, Katia Polato, Sonia Minuzzo, Giulia Borile, Paola Cogo, Silvia Campello, Alessandro Massi, Romeo Romagnoli, Barbara Buldini, Franco Locatelli, Martina Pigazzi

Blood Adv (2020) 4 (18): 4417–4429.

https://doi.org/10.1182/bloodadvances.2020002001

Published: 2020

Includes: Multimedia, Supplemental data

Journal Articles

Five decades of low intensity and low survival: adapting intensified regimens to cure pediatric Burkitt lymphoma in Africa

Nmazuo W. Ozuah, Joseph Lubega, Carl E. Allen, Nader Kim El-Mallawany

Blood Adv (2020) 4 (16): 4007–4019.

https://doi.org/10.1182/bloodadvances.2020002178

Published: 2020

Journal Articles

Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults

Blood Adv (2020) 4 (16): 3913–3925.

https://doi.org/10.1182/bloodadvances.2020001648

Published: 2020

Includes: Supplemental data

Journal Articles

Physical activity in children at risk of postthrombotic sequelae: a pilot randomized controlled trial

Rida Hasan, Maria Hanna, Song Zhang, Kendra Malone, Elizabeth Tong, Niavana Salas, Ravi Sarode, Janna Journeycake, Ayesha Zia

Blood Adv (2020) 4 (15): 3767–3775.

https://doi.org/10.1182/bloodadvances.2020002096

Published: 2020

Includes: Supplemental data

Journal Articles

Influence of single parenthood on cardiopulmonary function in pediatric patients with sickle cell anemia

Xu Zhang, Kiarri N. Kershaw, Caterina P. Minniti, Andrew Campbell, Sohail R. Rana, Deepika S. Darbari, Lori Luchtman-Jones, Craig Sable, Niti Dham, Gregory Ensing, Manuel Arteta, James G. Taylor, VI, Lewis L. Hsu, Sergei Nekhai, Victor R. Gordeuk

Blood Adv (2020) 4 (14): 3311–3314.

https://doi.org/10.1182/bloodadvances.2020002077

Published: 2020

Journal Articles

Risk factors for transplant-associated thrombotic microangiopathy and mortality in a pediatric cohort

Michelle Schoettler, Leslie E. Lehmann, Steven Margossian, Maia Lee, Leslie S. Kean, Pei-Chi Kao, Clement Ma, Christine N. Duncan

Blood Adv (2020) 4 (11): 2536–2547.

https://doi.org/10.1182/bloodadvances.2019001242

Published: 2020

Includes: Supplemental data

Journal Articles

Investigation of donor KIR content and matching in children undergoing hematopoietic cell transplantation for acute leukemia

Michael R. Verneris, Jeffrey S. Miller, Katherine C. Hsu, Tao Wang, Jennifer A. Sees, Sophie Paczesny, Hemalatha Rangarajan, Dean A. Lee, Stephen R. Spellman, Stephanie J. Lee

Blood Adv (2020) 4 (7): 1350–1356.

https://doi.org/10.1182/bloodadvances.2019001284

Published: 2020

Journal Articles

Keating AK, Langenhorst J, Wagner JE, et al. The influence of stem cell source on transplant outcomes for pediatric patients with acute myeloid leukemia. Blood Adv. 2019;3(7):1118-1128.

Blood Adv (2020) 4 (6): 1081.

https://doi.org/10.1182/bloodadvances.2020001753

Published: 2020

Journal Articles

Sex differences in the trajectory of glomerular filtration rate in pediatric and murine sickle cell anemia

Malgorzata Kasztan, Inmaculada Aban, Suraj P. Hande, David M. Pollock, Jeffrey D. Lebensburger

Blood Adv (2020) 4 (2): 263–265.

https://doi.org/10.1182/bloodadvances.2019001237

Published: 2020

Journal Articles

Bridging the gap: laboratory aspects of diagnosing pediatric hematologic malignancies at Yangon Children’s Hospital

Ei Ei Shwe, Ei Phyo Win, Thet Su Mon, Myat Hsu Mon, Darli Win, Aye Aye Khaing

Blood Adv (2019) 3 (Supplement 1): 31–33.

https://doi.org/10.1182/bloodadvances.2019GS121555

Published: 2019

NARROW

Spotlight on eltrombopag in pediatric ITP in China: a long-term observational study in real-world practice

Targeting pediatric leukemia-propagating cells with anti-CD200 antibody therapy

IFN-γ signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRS

The predictive value of PNH clones, 6p CN-LOH, and clonal TCR gene rearrangement for aplastic anemia diagnosis

A phase 2 study of nilotinib in pediatric patients with CML: long-term update on growth retardation and safety

Transplant-associated thrombotic microangiopathy in pediatric patients: pre-HSCT risk stratification and prophylaxis

Misdiagnosed thrombocytopenia in children and adolescents: analysis of the Pediatric and Adult Registry on Chronic ITP

Evolutionary insights into coagulation factor IX Padua and other high-specific-activity variants

Outcomes and prognostic factors in adolescents and young adults with ALL treated with a modified BFM-90 protocol

Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets

Thioridazine requires calcium influx to induce MLL-AF6 –rearranged AML cell death

Five decades of low intensity and low survival: adapting intensified regimens to cure pediatric Burkitt lymphoma in Africa

Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults

Physical activity in children at risk of postthrombotic sequelae: a pilot randomized controlled trial

Influence of single parenthood on cardiopulmonary function in pediatric patients with sickle cell anemia

Risk factors for transplant-associated thrombotic microangiopathy and mortality in a pediatric cohort

Investigation of donor KIR content and matching in children undergoing hematopoietic cell transplantation for acute leukemia

Keating AK, Langenhorst J, Wagner JE, et al. The influence of stem cell source on transplant outcomes for pediatric patients with acute myeloid leukemia. Blood Adv. 2019;3(7):1118-1128.

Sex differences in the trajectory of glomerular filtration rate in pediatric and murine sickle cell anemia

Bridging the gap: laboratory aspects of diagnosing pediatric hematologic malignancies at Yangon Children’s Hospital

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only